PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1419084
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1419084
Dupuytren's Disease Market size was valued at USD 4,131.00 Million in 2022, expanding at a CAGR of 4.44% from 2023 to 2030.
Dupuytren's disease causes Fascia, a layer of tissue beneath the skin, thickens abnormally in the palm of your hand near the base of your fingers. This enlarged region could turn into a thick band or hard lump.
The rising incidence of the illness is fueling the market's notable expansion. A growing number of patients need treatment choices, as evidenced by a recent study that was published in the Journal of Hand Surgery and showed a noticeable increase in diagnosed cases. To address the demand for efficient management techniques, pharmaceutical businesses and makers of medical devices have expanded their spending in research and development. Furthermore, according to a population survey conducted in the United States in 2021, up to 7% of people have clinical symptoms, and over one-third of those people are impacted by Dupuytren's contractures.
Furthermore, the growing number of technological and scientific developments in medicine also contributing to market growth. Stakeholders have potential to address patients' changing requirements and improve illness management results as the industry grows. The Journal of Hand Surgery highlights the need for more nonsurgical methods to treat Dupuytren's disease and encourages continuous dialogue among hand surgeons about new treatments and techniques.
The Global Dupuytren's Disease Market is segmented on the basis of Type, Disease Type, End-User, and Region.
The market is divided into two categories based on Type: diagnosis and treatment. The treatment segment dominates the market. Pharmaceutical companies are focusing on developing innovative treatment solutions for treatment of disease.
The market is divided into three categories based on Disease Type: Type I, Type II, and Type III. The Type II segment dominates the market and is likely to maintain its dominance during the forecast period. The growing prevalence of disease with digital cords impairment are likely to boost market growth.
The market is divided into four categories based on End-User: hospitals, clinics, research institutes, and others. The hospitals segment dominates the market and is likely to maintain its dominance during the forecast period. Hospitals provide holistic care treatment care and is expected to boost the market growth.
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
The market is expanding significantly because of rising patient numbers, improved treatment, and more awareness. Major players can take advantage of these opportunities by providing specialized care and efficient therapies. To increase their industry share, market players are constantly taking part in strategic activities including mergers, acquisitions, and partnerships. For example, in April 2022, 180 Life Sciences and the University of Oxford announced the publication of positive Phase 2b study results for Dupuytren's.
In April 2023, a newly launched specialty pharmaceutical company called Ventoux Biosciences, which is dedicated to transforming the management of fibrotic diseases, including Dupuytren's disease.
The scope of this report covers the market by its major segments, which include as follows: